Pfizer : PFE

All Pfizer Articles

1533 Articles

Trey Thoelcke | Sep 25, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Sep 12, 2019 at 8:35 AM EDT

Short Sellers Can’t Make Up Their Minds on Big Pharma

The August 30 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Sep 12, 2019 at 6:50 AM EDT

The 5 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Pfizer, Intel and Microsoft above all other Dow stocks.

Chris Lange | Aug 27, 2019 at 8:35 AM EDT

Big Pharma Sees a Rising Tide in Short Interest

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Aug 27, 2019 at 6:35 AM EDT

The 6 Most Shorted Dow Stocks

As of the most recently reported period, short sellers favored Intel, Pfizer and Microsoft above all other Dow stocks.

Jon C. Ogg | Aug 12, 2019 at 12:10 PM EDT

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current…

Chris Lange | Aug 12, 2019 at 8:40 AM EDT

Major Pharma Sees Rising Tide in Short Interest

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Trey Thoelcke | Aug 12, 2019 at 6:35 AM EDT

Pfizer Once Again the Most Shorted Dow Stock

As of the most recently reported period, short sellers still favored Pfizer, Intel and Microsoft above all other Dow stocks.

Jon C. Ogg | Aug 8, 2019 at 1:05 PM EDT

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Of the 40 worst performers in the S&P 500 so far in 2019, 11 are tied to oil and gas,…

Chris Lange | Aug 5, 2019 at 10:45 AM EDT

Is GlycoMimetics’ Sickle Cell Study Done For?

GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction…

Jon C. Ogg | Jul 30, 2019 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

The top analyst upgrades, downgrades and initiations seen on Tuesday included Cisco Systems, Duke Energy, Goodyear, Illumina, Kinder Morgan, Micron…

Chris Lange | Jul 29, 2019 at 12:05 PM EDT

What to Watch When Merck and Pfizer Report Early on Tuesday

Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of…

Chris Lange | Jul 29, 2019 at 9:25 AM EDT

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Mylan released its second-quarter financial results before the markets opened on Monday. The pharma giant also announced a major update…

Chris Lange | Jul 28, 2019 at 10:20 AM EDT

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week, including…

Douglas A. McIntyre | Jul 27, 2019 at 7:28 AM EDT

This Stock Is Killing the Dow

The Dow Jones industrial average in an all-time high territory, and a lot of experts believe it has room to…

1 … 29 30 31 32 33 … 103

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 6 Most Shorted Dow Stocks

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Pfizer Once Again the Most Shorted Dow Stock

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Is GlycoMimetics’ Sickle Cell Study Done For?

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

What to Watch When Merck and Pfizer Report Early on Tuesday

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

This Stock Is Killing the Dow

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

This is One of the Cheapest Magnificent Seven Stocks Right Now

Nvidia’s 15% Price Hike Reveals the Hidden Cost of the AI Boom

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

This is One of the Cheapest Magnificent Seven Stocks Right Now

Pfizer : PFE

All Pfizer Articles

The 6 Most Shorted Dow Stocks

Short Sellers Can’t Make Up Their Minds on Big Pharma

The 5 Most Shorted Dow Stocks

Big Pharma Sees a Rising Tide in Short Interest

The 6 Most Shorted Dow Stocks

Dividend Investors Have Reasons to Look to Big Biotech Over Big Pharma Ahead

Major Pharma Sees Rising Tide in Short Interest

Pfizer Once Again the Most Shorted Dow Stock

Oil & Gas, Apparel, Pharma Vying for S&P 500’s Worst Group of 2019

Is GlycoMimetics’ Sickle Cell Study Done For?

Top Analyst Upgrades and Downgrades: AppFolio, Cisco, Duke Energy, Goodyear, HyreCar, Illumina, Kinder Morgan, Micron, Pfizer, Tencent Music and More

What to Watch When Merck and Pfizer Report Early on Tuesday

What This Mylan-Pfizer Pharma Juggernaut Will Look Like

Apple, Chevron, Exxon, Pfizer, Verizon and More Dow Earnings This Week

This Stock Is Killing the Dow

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

This is One of the Cheapest Magnificent Seven Stocks Right Now

Nvidia’s 15% Price Hike Reveals the Hidden Cost of the AI Boom

Featured Reads

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

He Camped One Weekend on Riverfront Land Inside His IRA. Medicare Charged Him for It Two Years Later.